The shares of Las Vegas Sands Corp. (NYSE: LVS) and OncoSec Medical Incorporated (NASDAQ: ONCS) were among the active stocks of the last trading sessions. Las Vegas Sands Corp. (NYSE: LVS) rose to 2.09% closing at the price of $ 56.57 whereas the shares of OncoSec Medical Incorporated (NASDAQ: ONCS) dropped -1.51% with the decrease of -0.01 points closing at the price of $ 0.86. Las Vegas Sands Corp. has currently reduced-28.39% in its stock over the period of 6-months while its rival OncoSec Medical Incorporated subtracted -45.57% in the previous 6-months.
Now we have to analyze the facts that if the stocks were worthy off investors' money? The facts to analyze here are risks, profitability, returns and price trends.
Returns and Profitability
Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they will expect over the period of time.
The first and foremost return that is considered when making an investment is the ROI or Return on Investment. The ROI is the ratio between the cost of investment. Currently the ROI of Las Vegas Sands Corp. (NYSE: LVS) is 19.5% while the ROI of OncoSec Medical Incorporated (NASDAQ: ONCS) is 0%. Another figure that is to be considered While analyzing the profitability of a share is its EBITDA margin, LVS's EBITDA Margin is 9.86 while ONCS's is -2.19.
Both the profitability ratios suggest that Las Vegas Sands Corp. (NYSE: LVS) is more suitable investment in terms of profitability and return.
EPS & Surprise Factor
Las Vegas Sands Corp. (NYSE: LVS) reported $ 0.77 / share EPS for the previous quarter where analysts were predicting an EPS to be $ 0.81 / share Thus lagging the analyst Estimates with a Surprise Factor of -4.9 Percent. While, OncoSec Medical Incorporated (NASDAQ: ONCS) reported the EPS of $ -0.23 / share in the last quarter. The analysts projected EPS of $ -0.17 / share depicting a Surprise of -35.3 Percent.
Taking a look at Earnings per Share, Las Vegas Sands Corp. tends to be beating the analyst estimates more than OncoSec Medical Incorporated. so LVS is more profitable than ONCS.
Technical Analysis of Las Vegas Sands Corp. & OncoSec Medical Incorporated
Moving average convergence divergence (MACD) shows that Las Vegas Sands Corp. (NYSE: LVS) is on a PRICE RELATIVITY trend while OncoSec Medical Incorporated (NASDAQ: ONCS) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Las Vegas Sands Corp. was in BULLISH territory and OncoSec Medical Incorporated was in BEARISH territory.
LVS's current statistics gauge that the stock candle is BULLISH with high volatility. While ONCS's candle is BEARISH with HIGH.
EPS Growth Rate: LVS's 6.98% vs ONCS's 0%
Another shareholder value can be analyzed through the EPS growth rate; The next 5 years EPS growth rate is predicted by the analysts after the analysis of the previous trends. The next 5 year EPS growth rate of Las Vegas Sands Corp. (NYSE: LVS) is predicted at 6.98% while OncoSec Medical Incorporated (NASDAQ: ONCS) stands at 0%. These numbers suggest that LVS is more suitable investment in terms of EPS growth rate.
Financial Risk and Liquidity Concerns
The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of LVS stands at 1.9 while ONCS is at 4.9 whereas the debt ratio of the prior is 1.75 while the debt ratio of the later is 0.
The values of the both ratios suggest that one is more liquid and other investment is more risk free.
While making an investment, 1 is 5 is where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.3 for LVS and 2 for ONCS which means LVS has Hold rating whileas ONCS has Buy rating.
Another recommendation of an analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing in what extent the stock will rise or fall in the near future. The price target set for LVS is $ 68.26 which is 17.13% of its current price while the ONCS has a price target of 4.67 which is 81.58% of its current price.
Valuation is the process of determining the company's worth for an investor, valuation ratios give an insight to that worthiness.
LVS currently has the price to earning P / E ratio of 17.2 whereas ONCS has 0 while the forward P / E ratio for the previous stands at 16.37 and for the later it depicts the value of 0.
The price to Book P / B for LVS is 6.48, Price to Sale is at 3.28 and for ONCS these ratios stand at 2 and 0.